• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常和尿毒症红细胞对钠泵抑制剂的体内蓄积

In vivo accumulation of sodium pump inhibitor by normal and uremic erythrocytes.

作者信息

Gallice P, Lai E, Brunet P, Berland Y, Elsen R, Crevat A

机构信息

Biophysics Laboratory, Faculty of Pharmacy, Marseille, France.

出版信息

Int J Artif Organs. 1993 Mar;16(3):120-2.

PMID:8390969
Abstract

A uremic toxin fraction (fraction 2-3-1) in the middle molecular mass range (300-2000 Da) containing a sodium potassium inhibitor pump was studied. As fraction 2-3-1 was known to be present in minute quantities in urine and plasma, erythrocyte lysates were used as an alternative source. Results show that fraction 2-3-1 is more abundant in erythrocytes than in normal urine. In addition, the fraction is present in a greater quantity in uremic erythrocytes than in normal blood cells. It is concluded that fraction 2-3-1 is concentrated at the erythrocyte level in uremic patients.

摘要

对一种分子量处于中等范围(300 - 2000道尔顿)、含有钠钾抑制泵的尿毒症毒素组分(组分2 - 3 - 1)进行了研究。由于已知组分2 - 3 - 1在尿液和血浆中含量极少,因此使用红细胞裂解物作为替代来源。结果表明,组分2 - 3 - 1在红细胞中的含量比正常尿液中更为丰富。此外,该组分在尿毒症患者的红细胞中的含量高于正常血细胞。得出的结论是,组分2 - 3 - 1在尿毒症患者的红细胞水平上被浓缩。

相似文献

1
In vivo accumulation of sodium pump inhibitor by normal and uremic erythrocytes.正常和尿毒症红细胞对钠泵抑制剂的体内蓄积
Int J Artif Organs. 1993 Mar;16(3):120-2.
2
Separation from uremic body fluids and normal urine of Na+, K+-ATPase inhibitor.从尿毒症体液和正常尿液中分离钠钾-ATP酶抑制剂。
Adv Exp Med Biol. 1987;223:215-8. doi: 10.1007/978-1-4684-5445-1_33.
3
23Na nuclear magnetic resonance study of Na+-K+ pump inhibition by a fraction from uremic toxins.利用尿毒症毒素中的一种成分对钠钾泵抑制作用的23Na核磁共振研究
Clin Chem. 1988 Oct;34(10):2044-7.
4
Sodium pump activity in uremic erythrocytes: a microcalorimetric study.尿毒症红细胞中的钠泵活性:微量量热法研究
Int J Artif Organs. 1992 Mar;15(3):135-8.
5
Mechanism of alteration of sodium potassium pump of erythrocytes from patients with chronic renal failure.慢性肾功能衰竭患者红细胞钠钾泵改变的机制
J Clin Invest. 1984 Nov;74(5):1811-20. doi: 10.1172/JCI111600.
6
Ascorbic acid derivatives in two different fractions of uremic toxins.尿毒症毒素两个不同组分中的抗坏血酸衍生物。
Int J Artif Organs. 1991 Dec;14(12):754-8.
7
High-resolution NMR studies of transmembrane cation transport in uremic patients.尿毒症患者跨膜阳离子转运的高分辨率核磁共振研究。
Biochim Biophys Acta. 1990 Aug 10;1027(1):31-40. doi: 10.1016/0005-2736(90)90044-o.
8
Uremic toxins and the elusive middle molecules.尿毒症毒素与难以捉摸的中分子物质。
Nephron. 1984;38(1):1-8. doi: 10.1159/000183269.
9
Erythrocyte transport of middle molecular substances.
Proc Eur Dial Transplant Assoc. 1981;18:183-7.
10
[Study of middle molecules with positive reaction to ninhydrin present in uremic and normal blood and their isolation].
Minerva Nefrol. 1979 Jan-Mar;26(1):45-8.